Find the latest pharmaceutical market place for formulations enquiry about Deferoxamine Mesylate on PharmaCompass.com.

Various Finished Dosage Formulations needed in Jordan [ENA11630]

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with EU dossiers for each.
1. Natalizumab (20 mg/ ml in 15 ml) Concentrate for IV Solution. The required quantity is 5,700 units.
2. Deferoxamine mesylate (500 mg) Vials. The required quantity is 1,650,000 units.
3. Tocilizumab (200 mg/ 10 ml) Vials. The required quantity is 1,300 units.
4. Rituximab (500 mg) Vials. The required quantity is 36,000 units.

Reply

13 Oct 2021

Deferoxamine Mesylate (0.5 g & 1 g) Injections needed in Pakistan [ENA08235]

Alphaevolution Enterprises, an export/import oriented company based in Pakistan is looking for suppliers of Deferoxamine Mesylate (0.5 g & 1 g) Injections. The required quantity is 200,000 units for each. The suppliers must support this enquiry with dossiers. Interested suppliers can contact them via their email: alphaevolution@outlook.com.

Reply

14 Aug 2020

Looking for CTD dossier of Azithromycin and Deferoxamine injections [ENA05248]

A joint stock company owned by a group of Lebanese developing sterile injectables is looking for Azithromycin and Deferoxamine injections (CTD Dossier). The required dosage strength is 500 mg for each injection.

Reply

24 Sep 2019